SANTHERA PHARMACEUTICALS
Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases. This area of high unmet medical need includes many orphan and niche indications with no current therapy.
SANTHERA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2004-09-01
Address:
Liestal, Basel-Landschaft, Switzerland
Country:
Switzerland
Website Url:
http://www.santhera.com
Total Employee:
51+
Status:
Active
Contact:
41 61 906 89 50
Email Addresses:
[email protected]
Total Funding:
187.68 M USD
Technology used in webpage:
Euro Apple Whitelist
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
THC Pharm
THC Pharm develops drugs & medicinal products for the treatment of multimorbidity, cancer and neurological diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2009-08-17 | Juvantia Pharma | Juvantia Pharma acquired by Santhera Pharmaceuticals | N/A |
Investors List
Highbridge Capital Management
Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals
Highbridge Capital Management
Highbridge Capital Management investment in Post-IPO Equity - Santhera Pharmaceuticals
Waypoint Capital
Waypoint Capital investment in Post-IPO Equity - Santhera Pharmaceuticals
Idorsia
Idorsia investment in Post-IPO Equity - Santhera Pharmaceuticals
Highbridge Capital Management
Highbridge Capital Management investment in Post-IPO Debt - Santhera Pharmaceuticals
YA Global Master SPV
YA Global Master SPV investment in Post-IPO Equity - Santhera Pharmaceuticals
Ares Life Sciences
Ares Life Sciences investment in Post-IPO Equity - Santhera Pharmaceuticals
Neomed Management
Neomed Management investment in Series C - Santhera Pharmaceuticals
Carnegie Asset Management
Carnegie Asset Management investment in Series C - Santhera Pharmaceuticals
The Dow Chemical Company
The Dow Chemical Company investment in Series C - Santhera Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.santhera.com
- Host name: staging.santhera.com
- IP address: 139.162.164.211
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313